Senseonics Holdings reports into today's print carrying the scars of a brutal month — the stock fell nearly 20% in the past four weeks to $5.36, and short sellers have been steadily adding exposure throughout. Short interest has climbed to 12.9% of the free float, up roughly 5% over the past month and edging higher again in the days immediately before the report. The ORTEX short score of 79.3 places the stock in the top few percent of the universe for short pressure, a reading that has held stubbornly elevated all week. Borrow availability has tightened materially — earlier in April the lending pool ran at full capacity for several consecutive sessions, and while it has eased slightly since, the borrow market is nowhere near comfortable. Cost to borrow jumped 84% over the past week before pulling back to 2.76%, a signal that demand for short exposure spiked sharply ahead of the print.
Options positioning, by contrast, is only modestly defensive. The put/call ratio is running at 0.54, about one standard deviation above its 20-day average of 0.40 — elevated but far from the extreme hedging seen at past stress points, when the PCR touched 1.18. That gap matters: the lending market is telling a much more aggressive bearish story than the options market is.
The report itself offers both sides something to hold onto. Q1 revenue came in at $11.7 million, beating the $9.8 million consensus estimate by nearly 20% — a genuine beat driven by Eversense 365 patient additions. The EPS loss of $0.71, however, missed the $0.65 estimate, underscoring the persistent cash burn. Bulls point to the raised full-year 2026 sales guidance, lifted to $60–$64 million from the prior $58–$62 million range. That implies a meaningful revenue ramp in the back half and lines up with the bull case projection of gross margins crossing 50% by year-end — a steep climb from 43% in Q3 2025. Bears counter that the first half of the year was flagged as effectively flat, losses are widening on a per-share basis, and the company closed a $92 million public offering just days before the print, a dilutive move that likely contributed to the sharp price decline this month.
The pattern of past earnings reactions adds context that short sellers will find familiar: the two most recent prints both triggered double-digit selloffs, with the stock dropping roughly 13% in one day after the March 2026 report and extending that move to nearly 19% over the following five sessions. Today's print — a revenue beat paired with a wider-than-expected loss and a guidance raise — tests whether that reaction function has changed, or whether the market again prioritises the bottom-line miss over the top-line momentum.
See the live data behind this article on ORTEX.
Open SENS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
